Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency

S Balasubramaniam; L G Riley; D Bratkovic; D Ketteridge; N Manton; M J Cowley; V Gayevskiy; T Roscioli; M Mohamed; T Gardeitchik; E Morava; J Christodoulou

doi:10.1007/s10545-017-0036-4

Unique presentation of cutis laxa with Leigh-like syndrome due to ECHS1 deficiency

J Inherit Metab Dis. 2017 Sep;40(5):745-747. doi: 10.1007/s10545-017-0036-4. Epub 2017 Apr 13.

Authors

S Balasubramaniam^{1

2

3

4}, L G Riley^{5

6}, D Bratkovic⁷, D Ketteridge⁷, N Manton⁸, M J Cowley⁹, V Gayevskiy⁹, T Roscioli^{9

10

11}, M Mohamed^{12

13}, T Gardeitchik^{12

13}, E Morava^{12

14}, J Christodoulou^{15

16

5

6

17

18}

Affiliations

¹ Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia. [email protected].
² Genetic Metabolic Disorders Service, Western Sydney Genetics Program, The Children's Hospital at Westmead, Cnr Hawkerbusry Rd and Hainworth St, Locked Bag 4001, Westmead, 2145, NSW, Australia. [email protected].
³ Discipline of Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, NSW, 2145, Australia. [email protected].
⁴ Discipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia. [email protected].
⁵ Discipline of Paediatrics & Child Health, Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
⁶ Genetic Metabolic Disorders Research Unit, The Children's Hospital at Westmead, KRI, Sydney, NSW, 2145, Australia.
⁷ Metabolic Unit, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia.
⁸ Department of Surgical Pathology, SA Pathology, Women's and Children's Hospital, North Adelaide, 5006, SA, Australia.
⁹ Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
¹⁰ St Vincent's Clinical School, University of New South Wales, Sydney, NSW, 2010, Australia.
¹¹ Department of Medical Genetics, Sydney Children's Hospital, Randwick, Australia.
¹² Institute for Genetic and Metabolic Disease, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands.
¹³ Department of Pediatrics, Radboud University Medical Centre Nijmegen, Nijmegen, 6500, The Netherlands.
¹⁴ Hayward Genetics Center, Tulane University Medical Center, New Orleans, LA, USA.
¹⁵ Western Sydney Genetics Program, The Children's Hospital at Westmead, Sydney, NSW, 2145, Australia.
¹⁶ Discipline of Genetic Medicine, Sydney Medical School, University of Sydney, Sydney, NSW, 2145, Australia.
¹⁷ Murdoch Children's Research Institute and Victorian Clinical Genetics Services, Royal Children's Hospital, Melbourne, VIC, Australia.
¹⁸ Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia.

PMID: 28409271
DOI: 10.1007/s10545-017-0036-4

Abstract

Clinical finding of cutis laxa, characterized by wrinkled, redundant, sagging, nonelastic skin, is of growing significance due to its occurrence in several different inborn errors of metabolism (IEM). Metabolic cutis laxa results from Menkes syndrome, caused by a defect in the ATPase copper transporting alpha (ATP7A) gene; congenital disorders of glycosylation due to mutations in subunit 7 of the component of oligomeric Golgi (COG7)-congenital disorders of glycosylation (CDG) complex; combined disorder of N- and O-linked glycosylation, due to mutations in ATPase H+ transporting V0 subunit a2 (ATP6VOA2) gene; pyrroline-5-carboxylate reductase 1 deficiency; pyrroline-5-carboxylate synthase deficiency; macrocephaly, alopecia, cutis laxa, and scoliosis (MACS) syndrome, due to Ras and Rab interactor 2 (RIN2) mutations; transaldolase deficiency caused by mutations in the transaldolase 1 (TALDO1) gene; Gerodermia osteodysplastica due to mutations in the golgin, RAB6-interacting (GORAB or SCYL1BP1) gene; and mitogen-activated pathway (MAP) kinase defects, caused by mutations in several genes [protein tyrosine phosphatase, non-receptor-type 11 (PTPN11), RAF, NF, HRas proto-oncogene, GTPase (HRAS), B-Raf proto-oncogene, serine/threonine kinase (BRAF), MEK1/2, KRAS proto-oncogene, GTPase (KRAS), SOS Ras/Rho guanine nucleotide exchange factor 2 (SOS2), leucine rich repeat scaffold protein (SHOC2), NRAS proto-oncogene, GTPase (NRAS), and Raf-1 proto-oncogene, serine/threonine kinase (RAF1)], which regulate the Ras-MAPK cascade. Here, we further expand the list of inborn errors of metabolism associated with cutis laxa by describing the clinical presentation of a 17-month-old girl with Leigh-like syndrome due to enoyl coenzyme A hydratase, short chain, 1, mitochondria (ECHS1) deficiency, a mitochondrial matrix enzyme that catalyzes the second step of the beta-oxidation spiral of fatty acids and plays an important role in amino acid catabolism, particularly valine.

Keywords: Compound Heterozygous Variant; Cutis Laxa; Mitochondrial Matrix Enzyme; Respiratory Chain Enzyme Activity; Transaldolase.

Publication types

Case Reports

MeSH terms

Cutis Laxa / genetics*
Enoyl-CoA Hydratase / deficiency*
Female
Humans
Infant
Leigh Disease / genetics*
Proto-Oncogene Mas

Substances

MAS1 protein, human
Proto-Oncogene Mas
ECHS1 protein, human
Enoyl-CoA Hydratase

Abstract

Publication types

MeSH terms

Substances

Grants and funding